Duvelisib

Brand Name

Copiktra170,171,#

Pharmacology

Antineoplastic, phosphoinosi-tide-3 kinase (PI3Kδ and PI3Kγ) inhibitor

FDA Indication

Chronic lymphocytic leukemia; small lymphocytic lymphoma; follicular lymphoma

Similars

Copanlisib (PI3K-α and PI3K-δ inhibitor), idelalisib (PI3K-δ inhibitor)

Further Reading in Goodman & Gilman’s